|
|
NEW YORK, NY / ACCESWIRE / March 18, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $10 Million Underwritten Public Offering of Common Shares for Tantech Holdings Ltd. NASDAQ:TANH.Tantech Holdings Ltd.For the past decade, Tantech has been a highly specialized hightech enterprise producing, researching and developing bamboo charcoalbased products with an established domestic and... Lire le communiqué |
|
| |
|
| |
|
|
NEW YORK, NY / ACCESSWIRE / March 15, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. NASDAQ:SBFMAbout Sunshine Biopharma, Inc.Severe Acute Respiratory SyndromeCoronavirus2 SARSCoV2 is the causative agent of the ongoing COVID19 pandemic that has claimed the lives of over 5.3 million people worldwide since it first... Lire le communiqué |
|
| |
|
| |
|
|
NEW YORK, NY / ACCESSWIRE / February 17, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine Biopharma Inc.NASDAQ:SBFM; SBFMWAbout Sunshine Biopharma, Inc.Severe Acute Respiratory SyndromeCoronavirus2 SARSCoV2 is the causative agent of the ongoing COVID19 pandemic that has claimed the lives of over 5.3 million people... Lire le communiqué |
|
| |
|
| |
|
|
NEW YORK, NY / ACCESSWIRE / January 21, 2022 / Aegis Capital Corp. "Aegis" a fullservice wealth management, financial services and investment banking firm is pleased to announce that Andrew L. Johnson joined the firm as an Executive Vice President of Investment Banking.Andrew L. Johnson has extensive experience in several facets of the investment banking process in the small and mid cap... Lire le communiqué |
|
| |
|
| |
|
|
NEW YORK, NY / ACCESSWIRE / January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the OverAllotment, for China SXT Pharmaceuticals, Inc. NASDAQ:SXTC.About China SXT Pharmaceuticals, Inc.Founded in 2005 and headquartered in Taizhou City, Jiangsu Province, China, China S... Lire le communiqué |
|
| |
|
| |
|
|
NEW YORK, NY / ACCESSWIRE / January 3, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $9.8 Million Underwritten Public Offering of ADSs for BiondVax Pharmaceuticals Ltd. NASDAQ:BVXV.About BiondVax Pharmaceuticals Ltd.BiondVax Pharmaceuticals Ltd. Nasdaq:BVXV is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative product... Lire le communiqué |
|
| |
|
| |
|
|
NEW YORK, NY / ACCESSWIRE / December 22, 2021 / Aegis Capital Corp. "Aegis" a fullservice wealth management, financial services and investment banking firm is pleased to announce that Snigdha Adhikari has joined the business development department as a Senior Vice President of Business DevelopmentSnigdha has been in the financial services industry for over 14 years, most of which she... Lire le communiqué |
|
| |
|
| |
